Coimmunoprecipitation of FAT/CD36 and CPT I in skeletal muscle increases proportionally with fat oxidation after endurance exercise training

American Journal of Physiology - Endocrinology and Metabolism

Volumn 291, Issue 2, 2006, Pages

  Schenk, Simon ^a   Horowitz, Jeffrey F ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Carnitine palmitoyltransferase I; Fatty acid translocase; Mitochondria; Obesity; Weight loss

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE 1 ENZYME; CD36 ANTIGEN; CYCLOOXYGENASE 1; UNCLASSIFIED DRUG;

ABSORPTION; ADULT; AEROBIC EXERCISE; ARTICLE; BODY COMPOSITION; BODY FAT; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIET; ENDURANCE; ENZYME LOCALIZATION; EXERCISE; FEMALE; FITNESS; HEALTH PROGRAM; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; LIPID OXIDATION; OBESITY; PRIORITY JOURNAL; SKELETAL MUSCLE; WEIGHT REDUCTION;

ADULT; ANTIGENS, CD36; CARNITINE O-PALMITOYLTRANSFERASE; DIET THERAPY; EXERCISE; EXERCISE THERAPY; FATS; FEMALE; HUMANS; IMMUNOPRECIPITATION; MUSCLE, SKELETAL; OBESITY; OXIDATION-REDUCTION; PHYSICAL ENDURANCE; WEIGHT LOSS;

EID: 33745818883     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00051.2006     Document Type: Article

References (34)

1. Arkinstall MJ, Tunstall RJ, Cameron-Smith D, and Hawley JA. Regulation of metabolic genes in human skeletal muscle by short-term exercise and diet manipulation. Am J Physiol Endocrinol Metab 287: E25-E31, 2004.
2. Berggren JR, Hulver MW, Dohm GL, and Houmard JA. Weight loss and exercise: implications for muscle lipid metabolism and insulin action. Med Sci Sports Exerc 36: 1191-1195, 2004.
3. Bezaire V, Bruce CR, Heigenhauser GJ, Tandon NN, Glatz JF, Luiken JJ, Bonen A, and Spriet LL. Identification of fatty acid translocase on human skeletal muscle mitochondrial membranes: essential role in fatty acid oxidation. Am J Physiol Endocrinol Metab 290: E509-E515, 2006.
4. Bonen A, Dyck DJ, Ibrahimi A, and Abumrad NA. Muscle contractile activity increases fatty acid metabolism and transport and FAT/CD36. Am J Physiol Endocrinol Metab 276: E642-E649, 1999.
5. Bonen A, Luiken JJ, Arumugam Y, Glatz JF, and Tandon NN. Acute regulation of fatty acid uptake involves the cellular redistribution of fatty acid translocase. J Biol Chem 275: 14501-14508, 2000.
6. Brady PS, Ramsay RR, and Brady LJ. Regulation of the long-chain carnitine acyltransferases. FASEB J 7: 1039-1044, 1993.
7. Bruce CR, Anderson MJ, Carey AL, Newman DG, Bonen A, Kriketos AD, Cooney GJ, and Hawley JA. Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status. J Clin Endocrinol Metab 88: 5444-5451, 2003.
8. Cameron-Smith D, Burke LM, Angus DJ, Tunstall RJ, Cox GR, Bonen A, Hawley JA, and Hargreaves M. A short-term, high-fat diet up-regulates lipid metabolism and gene expression in human skeletal muscle. Am J Clin Nutr 77: 313-318, 2003.
9. Campbell SE, Tandon NN, Woldegiorgis G, Luiken JJ, Glatz JF, and Bonen A. A novel function for fatty acid translocase (FAT)/CD36: involvement in long chain fatty acid transfer into the mitochondria. J Biol Chem 279: 36235-36241, 2004.
10. Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 55: 628-634, 1983.
11. García-Martínez C, Marotta M, Moore-Carrasco R, Guitart M, Camps M, Busquets S, Montell E, and Gómez-Foix AM. Impact on fatty acid metabolism and differential localization of FATP1 and FAT/CD36 proteins delivered in cultured human muscle cells. Am J Physiol Cell Physiol 288: C1264-C1272, 2005.
12. Glatz JF, Luiken JJ, and Bonen A. Involvement of membrane-associated proteins in the acute regulation of cellular fatty acid uptake. J Mol Neurosci 16: 123-132; Discussion 151-127, 2001.
13. Goedecke JH, St Clair Gibson A, Grobler L, Collins M, Noakes TD, and Lambert EV. Determinants of the variability in respiratory exchange ratio at rest and during exercise in trained athletes. Am J Physiol Endocrinol Metab 279: E1325-E1334, 2000.
14. Goodpaster BH, Katsiaras A, and Kelley DE. Enhanced fat oxidation through physical activity is associated with improvements in insulin sensitivity in obesity. Diabetes 52: 2191-2197, 2003.
15. Holloszy JO. Biochemical adaptations in muscle. Effects of exercise on mitochondrial oxygen uptake and respiratory enzyme activity in skeletal muscle. J Biol Chem 242: 2278-2282, 1967.
16. Holloway GP, Bezaire V, Heigenhauser GJ, Tandon NN, Glatz JF, Luiken JJ, Bonen A, and Spriet LL. Mitochondrial long chain fatty acid oxidation, fatty acid translocase/CD36 content and carnitine palmitoyltransferase I activity in human skeletal muscle during aerobic exercise. J Physiol 571: 201-210, 2006.
17. Horowitz JF, Coppack SW, Paramore D, Cryer PE, Zhao G, and Klein S. Effect of short-term fasting on lipid kinetics in lean and obese women. Am J Physiol Endocrinol Metab 276: E278-E284, 1999.
18. Itani SI, Ruderman NB, Schmieder F, and Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51: 2005-2011, 2002.
19. Keizer HA, Schaart G, Tandon NN, Glatz JF, and Luiken JJ. Subcellular immunolocalisation of fatty acid translocase (FAT)/CD36 in human type-1 and type-2 skeletal muscle fibres. Histochem Cell Biol 121: 101-107, 2004.
20. Kelley DE, Goodpaster B, Wing RR, and Simoneau JA. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol Endocrinol Metab 277: E1130-E1141, 1999.
21. Kiens B. Skeletal muscle lipid metabolism in exercise and insulin resistance. Physiol Rev 86: 205-243, 2006.
22. McGarry JD and Brown NF. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem 244: 1-14, 1997.
23. Menshikova EV, Ritov VB, Toledo FG, Ferrell RE, Goodpaster BH, and Kelley DE. Effects of weight loss and physical activity on skeletal muscle mitochondrial function in obesity. Am J Physiol Endocrinol Metab 288: E818-E825, 2005.
24. Petersen KF, Dufour S, Befroy D, Garcia R, and Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350: 664-671, 2004.
25. Pilegaard H, Osada T, Andersen LT, Helge JW, Saltin B, and Neufer PD. Substrate availability and transcriptional regulation of metabolic genes in human skeletal muscle during recovery from exercise. Metabolism 54: 1048-1055, 2005.
26. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, and Shulman GI. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97: 2859-2865, 1996.
27. Santomauro AT, Boden G, Silva ME, Rocha DM, Santos RF, Ursich MJ, Strassmann PG, and Wajchenberg BL. Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes 48: 1836-1841, 1999.
28. Simoneau JA, Veerkamp JH, Turcotte LP, and Kelley DE. Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss. FASEB J 13: 2051-2060, 1999.
29. Thiebaud D, DeFronzo RA, Jacot E, Golay A, Acheson K, Maeder E, Jequier E, and Felber JP. Effect of long chain triglyceride infusion on glucose metabolism in man. Metabolism 31: 1128-1136, 1982.
30. Tunstall RJ, Mehan KA, Wadley GD, Collier GR, Bonen A, Hargreaves M, and Cameron-Smith D. Exercise training increases lipid metabolism gene expression in human skeletal muscle. Am J Physiol Endocrinol Metab 283: E66-E72, 2002.
31. US National Heart, Lung, and Blood Institute. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. NIH Publ. No. 98-4083 (http://www.nhlbi.nih.gov/guidelines/obesity/ob_gdlns.pdf) , 1998.
32. Vistisen B, Roepstorff K, Roepstorff C, Bonen A, van Deurs B, and Kiens B. Sarcolemmal FAT/CD36 in human skeletal muscle colocalizes with caveolin-3 and is more abundant in type 1 than in type 2 fibers. J Lipid Res 45: 603-609, 2004.
33. Weir JB. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 109: 1-9, 1949.
34. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ, Atcheson B, White MF, Kraegen EW, and Shulman GI. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277: 50230-50236, 2002.